Browse by Title

Type here to filter the list

Q
Quantifying the Impact of Novel Metastatic Cancer Therapies on Health Disparities in Survival Outcomes Based on Published Aggregate Data

Karolina Zebrowska – Lumen Value & Access, Healthcare Consultancy Group ### 1991708###Co-Author######Lumen Value & Access, Healthcare Consultancy Group###
Co-Author: Karolina Zebrowska – Lumen Value & Access, Healthcare Consultancy Group
### @@@ Rosa C. Banuelos, PhD – Lumen Value & Access, Healthcare Consultancy Group ### 1657562###Co-Author###Senior Statistician###Lumen Value & Access, Healthcare Consultancy Group###
Co-Author: Rosa C. Banuelos, PhD – Lumen Value & Access, Healthcare Consultancy Group
### @@@ Evelyn J. Rizzo, MSc – Lumen Value & Access, Healthcare Consultancy Group ### 1657563###Co-Author###Consultant###Lumen Value & Access, Healthcare Consultancy Group###
Co-Author: Evelyn J. Rizzo, MSc – Lumen Value & Access, Healthcare Consultancy Group
### @@@ Kathy W. Belk, BA – Lumen Value & Access, Healthcare Consultancy Group ### 1657565###Co-Author###Vice President###Lumen Value & Access, Healthcare Consultancy Group###
Co-Author: Kathy W. Belk, BA – Lumen Value & Access, Healthcare Consultancy Group
### @@@ Gary Schneider, MSPH, ScD – Lumen Value & Access, Healthcare Consultancy Group ### 1991709###Presenting Author###VP, Real World Evidence, Analytics & Innovation###Lumen Value & Access, Healthcare Consultancy Group###
Presenting Author: Gary Schneider, MSPH, ScD – Lumen Value & Access, Healthcare Consultancy Group
### @@@ Koen Degeling, PhD – Lumen Value & Access, Healthcare Consultancy Group ### 1657564###Co-Author###Scientific Director & Decision-Analytic Modeling Lead###Lumen Value & Access, Healthcare Consultancy Group###
Co-Author: Koen Degeling, PhD – Lumen Value & Access, Healthcare Consultancy Group
###